Role of the Stress- and Inflammation-Induced Cytokine GDF-15 in Cardiovascular Diseases: From Basic Research to Clinical Relevance

Stress- and inflammation-induced growth differentiation factor-15 (GDF-15) is proposed as a biomarker for mortality and disease progression in patients with atherosclerosis and/or cardiovascular disease (CVD). The development of atherosclerotic lesions depends, among other factors, on inflammatory p...

Full description

Bibliographic Details
Main Authors: Anja Schwarz, Ralf Kinscherf, Gabriel A. Bonaterra
Format: Article
Language:English
Published: IMR Press 2023-03-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/24/3/10.31083/j.rcm2403081
_version_ 1797861267035127808
author Anja Schwarz
Ralf Kinscherf
Gabriel A. Bonaterra
author_facet Anja Schwarz
Ralf Kinscherf
Gabriel A. Bonaterra
author_sort Anja Schwarz
collection DOAJ
description Stress- and inflammation-induced growth differentiation factor-15 (GDF-15) is proposed as a biomarker for mortality and disease progression in patients with atherosclerosis and/or cardiovascular disease (CVD). The development of atherosclerotic lesions depends, among other factors, on inflammatory processes, oxidative stress, and impaired lipid homeostasis. As a consequence, activation and dysfunction of endothelial cells, release of chemokines, growth factors and lipid mediators occur. GDF-15 is suggested as an acute-phase modifier of transforming growth factor (TGF)-ßRII-dependent pro-inflammatory responses leading to rupture of atherosclerotic plaques, although the exact biological function is poorly understood to date. GDF-15 is upregulated in many disease processes, and its effects may be highly context-dependent. To date, it is unclear whether the upregulation of GDF-15 leads to disease progression or provides protection against disease. Concerning CVD, cardiomyocytes are already known to produce and release GDF-15 in response to angiotensin II stimulation, ischemia, and mechanical stretch. Cardiomyocytes, macrophages, vascular smooth muscle cells, endothelial cells, and adipocytes also release GDF-15 in response to oxidative as well as metabolic stress or stimulation with pro-inflammatory cytokines. Given the critically discussed pathophysiological and cellular functions and the important clinical significance of GDF-15 as a biomarker in CVD, we have summarized here the basic research findings on different cell types. In the context of cellular stress and inflammation, we further elucidated the signaling pathway of GDF-15 in coronary artery disease (CAD), the most common CVD in developing and industrial nations.
first_indexed 2024-04-09T21:59:29Z
format Article
id doaj.art-2497bdb9c3b941ecb0e502c7999f8c37
institution Directory Open Access Journal
issn 1530-6550
language English
last_indexed 2024-04-09T21:59:29Z
publishDate 2023-03-01
publisher IMR Press
record_format Article
series Reviews in Cardiovascular Medicine
spelling doaj.art-2497bdb9c3b941ecb0e502c7999f8c372023-03-24T02:12:28ZengIMR PressReviews in Cardiovascular Medicine1530-65502023-03-012438110.31083/j.rcm2403081S1530-6550(23)00901-8Role of the Stress- and Inflammation-Induced Cytokine GDF-15 in Cardiovascular Diseases: From Basic Research to Clinical RelevanceAnja Schwarz0Ralf Kinscherf1Gabriel A. Bonaterra2Department of Medical Cell Biology, Institute for Anatomy and Cell Biology, Philipps-University of Marburg, 35037 Marburg, GermanyDepartment of Medical Cell Biology, Institute for Anatomy and Cell Biology, Philipps-University of Marburg, 35037 Marburg, GermanyDepartment of Medical Cell Biology, Institute for Anatomy and Cell Biology, Philipps-University of Marburg, 35037 Marburg, GermanyStress- and inflammation-induced growth differentiation factor-15 (GDF-15) is proposed as a biomarker for mortality and disease progression in patients with atherosclerosis and/or cardiovascular disease (CVD). The development of atherosclerotic lesions depends, among other factors, on inflammatory processes, oxidative stress, and impaired lipid homeostasis. As a consequence, activation and dysfunction of endothelial cells, release of chemokines, growth factors and lipid mediators occur. GDF-15 is suggested as an acute-phase modifier of transforming growth factor (TGF)-ßRII-dependent pro-inflammatory responses leading to rupture of atherosclerotic plaques, although the exact biological function is poorly understood to date. GDF-15 is upregulated in many disease processes, and its effects may be highly context-dependent. To date, it is unclear whether the upregulation of GDF-15 leads to disease progression or provides protection against disease. Concerning CVD, cardiomyocytes are already known to produce and release GDF-15 in response to angiotensin II stimulation, ischemia, and mechanical stretch. Cardiomyocytes, macrophages, vascular smooth muscle cells, endothelial cells, and adipocytes also release GDF-15 in response to oxidative as well as metabolic stress or stimulation with pro-inflammatory cytokines. Given the critically discussed pathophysiological and cellular functions and the important clinical significance of GDF-15 as a biomarker in CVD, we have summarized here the basic research findings on different cell types. In the context of cellular stress and inflammation, we further elucidated the signaling pathway of GDF-15 in coronary artery disease (CAD), the most common CVD in developing and industrial nations.https://www.imrpress.com/journal/RCM/24/3/10.31083/j.rcm2403081gdf-15inflammationstresscoronary artery disease
spellingShingle Anja Schwarz
Ralf Kinscherf
Gabriel A. Bonaterra
Role of the Stress- and Inflammation-Induced Cytokine GDF-15 in Cardiovascular Diseases: From Basic Research to Clinical Relevance
Reviews in Cardiovascular Medicine
gdf-15
inflammation
stress
coronary artery disease
title Role of the Stress- and Inflammation-Induced Cytokine GDF-15 in Cardiovascular Diseases: From Basic Research to Clinical Relevance
title_full Role of the Stress- and Inflammation-Induced Cytokine GDF-15 in Cardiovascular Diseases: From Basic Research to Clinical Relevance
title_fullStr Role of the Stress- and Inflammation-Induced Cytokine GDF-15 in Cardiovascular Diseases: From Basic Research to Clinical Relevance
title_full_unstemmed Role of the Stress- and Inflammation-Induced Cytokine GDF-15 in Cardiovascular Diseases: From Basic Research to Clinical Relevance
title_short Role of the Stress- and Inflammation-Induced Cytokine GDF-15 in Cardiovascular Diseases: From Basic Research to Clinical Relevance
title_sort role of the stress and inflammation induced cytokine gdf 15 in cardiovascular diseases from basic research to clinical relevance
topic gdf-15
inflammation
stress
coronary artery disease
url https://www.imrpress.com/journal/RCM/24/3/10.31083/j.rcm2403081
work_keys_str_mv AT anjaschwarz roleofthestressandinflammationinducedcytokinegdf15incardiovasculardiseasesfrombasicresearchtoclinicalrelevance
AT ralfkinscherf roleofthestressandinflammationinducedcytokinegdf15incardiovasculardiseasesfrombasicresearchtoclinicalrelevance
AT gabrielabonaterra roleofthestressandinflammationinducedcytokinegdf15incardiovasculardiseasesfrombasicresearchtoclinicalrelevance